309 related articles for article (PubMed ID: 34468173)
1. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
2.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
4. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
5. Sulfonated azo dyes enhance the genome release of enterovirus A71 VP1-98K variants by preventing the virions from being trapped by sulfated glycosaminoglycans at acidic pH.
Meng T; Wong SM; Chua KB
Virology; 2021 Mar; 555():19-34. PubMed ID: 33422703
[TBL] [Abstract][Full Text] [Related]
6. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
7. Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study.
Chua KB; Ng Q; Meng T; Jia Q
Viruses; 2021 Mar; 13(3):. PubMed ID: 33803356
[TBL] [Abstract][Full Text] [Related]
8. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.
Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S
J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967
[TBL] [Abstract][Full Text] [Related]
9. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
10. Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet Nam.
Geoghegan JL; Tan le V; Kühnert D; Halpin RA; Lin X; Simenauer A; Akopov A; Das SR; Stockwell TB; Shrivastava S; Ngoc NM; Uyen le TT; Tuyen NT; Thanh TT; Hang VT; Qui PT; Hung NT; Khanh TH; Thinh le Q; Nhan le NT; Van HM; Viet do C; Tuan HM; Viet HL; Hien TT; Chau NV; Thwaites G; Grenfell BT; Stadler T; Wentworth DE; Holmes EC; Van Doorn HR
J Virol; 2015 Sep; 89(17):8871-9. PubMed ID: 26085170
[TBL] [Abstract][Full Text] [Related]
11. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
[TBL] [Abstract][Full Text] [Related]
12. Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.
Lee YP; Yu CK; Wong TW; Chen LC; Huang BM
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543718
[TBL] [Abstract][Full Text] [Related]
13. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years.
Huang SW; Cheng D; Wang JR
J Biomed Sci; 2019 Oct; 26(1):81. PubMed ID: 31630680
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
16. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
17. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
18. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
[TBL] [Abstract][Full Text] [Related]
19. Isolation of an imported subgenotype B5 strain of human enterovirus A71 in Chongqing City, China, 2014.
Yang Q; Zhang Y; Yan D; Zhu S; Wang D; Ji T; Huang W; An H; Xu W
Virol J; 2016 Jun; 13():115. PubMed ID: 27357279
[TBL] [Abstract][Full Text] [Related]
20. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
